Assenagon Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184M Buy
1,776,295
+899,942
+103% +$80.3M 0.23% 78
2026
Q1
$62.9M Sell
876,353
-2,079,660
-70% -$160M 0.1% 161
2025
Q4
$235M Buy
2,956,013
+370,926
+14% +$29.2M 0.32% 53
2025
Q3
$195M Buy
2,585,087
+861,140
+50% +$59M 0.27% 73
2025
Q2
$119M Sell
1,723,947
-1,799,877
-51% -$118M 0.18% 116
2025
Q1
$239M Buy
3,523,824
+2,666,029
+311% +$160M 0.4% 46
2024
Q4
$38.5M Sell
857,795
-1,134,375
-57% -$63.6M 0.06% 249
2024
Q3
$125M Buy
1,992,170
+659,928
+50% +$38.5M 0.23% 77
2024
Q2
$78.7M Buy
1,332,242
+1,077,027
+422% +$67.4M 0.18% 97
2024
Q1
$20.4M Sell
255,215
-1,911,885
-88% -$146M 0.05% 277
2023
Q4
$171M Buy
2,167,100
+1,049,871
+94% +$74.7M 0.45% 39
2023
Q3
$78M Sell
1,117,229
-1,685,926
-60% -$119M 0.24% 69
2023
Q2
$194M Buy
2,803,155
+569,291
+25% +$40.5M 0.67% 25
2023
Q1
$166M Buy
2,233,864
+666,483
+43% +$55.9M 0.59% 35
2022
Q4
$146M Buy
1,567,381
+712,595
+83% +$68.8M 0.53% 36
2022
Q3
$81.5M Buy
854,786
+143,611
+20% +$14.2M 0.31% 72
2022
Q2
$65.9M Buy
711,175
+681,051
+2,261% +$66.5M 0.24% 89
2022
Q1
$3.05M Buy
30,124
+16,289
+118% +$1.71M 0.01% 681
2021
Q4
$1.43M Sell
13,835
-166,365
-92% -$15.4M ﹤0.01% 943
2021
Q3
$15.3M Buy
+180,200
New +$15.1M 0.05% 238
2021
Q2
Sell
-29,225
Closed -$2.2M 1247
2021
Q1
$2.2M Sell
29,225
-132,905
-82% -$9.68M 0.01% 691
2020
Q4
$11.1M Buy
162,130
+46,239
+40% +$3.01M 0.05% 231
2020
Q3
$6.77M Buy
115,891
+103,036
+802% +$6.41M 0.04% 266
2020
Q2
$835K Sell
12,855
-237,469
-95% -$15M 0.01% 864
2020
Q1
$14.9M Buy
250,324
+229,451
+1,099% +$15.3M 0.12% 130
2019
Q4
$1.55M Sell
20,873
-322,896
-94% -$22.7M 0.01% 491
2019
Q3
$21.7M Buy
343,769
+318,384
+1,254% +$18.9M 0.15% 108
2019
Q2
$1.38M Sell
25,385
-1,176,097
-98% -$63.3M 0.01% 635
2019
Q1
$64.8M Buy
1,201,482
+643,107
+115% +$39.7M 0.61% 37
2018
Q4
$36.6M Buy
558,375
+546,385
+4,557% +$40.8M 0.41% 59
2018
Q3
$944K Sell
11,990
-16,561
-58% -$1.18M 0.01% 650
2018
Q2
$1.84M Buy
28,551
+7,231
+34% +$477K 0.02% 338
2018
Q1
$1.33M Sell
21,320
-2,254
-10% -$162K 0.02% 365
2017
Q4
$1.71M Sell
23,574
-695
-3% -$50.5K 0.02% 461
2017
Q3
$1.97M Buy
24,269
+13,742
+131% +$1.09M 0.02% 332
2017
Q2
$847K Buy
10,527
+273
+3% +$21.6K 0.02% 161
2017
Q1
$805K Sell
10,254
-78,498
-88% -$6.27M 0.02% 181
2016
Q4
$7M Buy
+88,752
New +$7.18M 0.13% 120

Other funds holding CVS

Assenagon Asset Management's CVS Position: Q2 2026 in Review

Assenagon Asset Management increased its CVS Health (CVS) stake by 103% in Q2 2026, buying an estimated $80.3M and bringing the position to 1,776,295 shares worth $184M. The position accounts for 0.23% of the portfolio, ranked #78.

Assenagon Asset Management first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $239M in Q1 2025. 844 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Assenagon Asset Management held 1,776,295 shares of CVS Health worth $184M as of Q2 2026.
  • Assenagon Asset Management bought 899,942 CVS Health shares in Q2 2026, an estimated $80.3M.
  • CVS Health made up 0.23% of Assenagon Asset Management's portfolio in Q2 2026, its #78 holding.
  • Assenagon Asset Management first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
  • Assenagon Asset Management's CVS Health position peaked at $239M in Q1 2025.
  • 844 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.